Fisher Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-58,742
| Closed | -$1.26M | – | 1185 |
|
|
2023
Q2 | $1.26M | Hold |
58,742
| – | – | ﹤0.01% | 730 |
|
|
2023
Q1 | $1.41M | Sell |
58,742
-6,477
| -10% | -$155K | ﹤0.01% | 708 |
|
|
2022
Q4 | $1.51M | Hold |
65,219
| – | – | ﹤0.01% | 697 |
|
|
2022
Q3 | $1.05M | Hold |
65,219
| – | – | ﹤0.01% | 659 |
|
|
2022
Q2 | $1.16M | Buy |
65,219
+14,800
| +29% | +$262K | ﹤0.01% | 609 |
|
|
2022
Q1 | $1.03M | Buy |
50,419
+10,826
| +27% | +$221K | ﹤0.01% | 626 |
|
|
2021
Q4 | $740K | Buy |
39,593
+19,244
| +95% | +$360K | ﹤0.01% | 689 |
|
|
2021
Q3 | $402K | Buy |
20,349
+5,254
| +35% | +$104K | ﹤0.01% | 761 |
|
|
2021
Q2 | $357K | Hold |
15,095
| – | – | ﹤0.01% | 777 |
|
|
2021
Q1 | $358K | Hold |
15,095
| – | – | ﹤0.01% | 754 |
|
|
2020
Q4 | $302K | Sell |
15,095
-5,755
| -28% | -$115K | ﹤0.01% | 791 |
|
|
2020
Q3 | $434K | Sell |
20,850
-6,756
| -24% | -$141K | ﹤0.01% | 684 |
|
|
2020
Q2 | $483K | Sell |
27,606
-8,138
| -23% | -$142K | ﹤0.01% | 659 |
|
|
2020
Q1 | $584K | Hold |
35,744
| – | – | ﹤0.01% | 601 |
|
|
2019
Q4 | $736K | Hold |
35,744
| – | – | ﹤0.01% | 622 |
|
|
2019
Q3 | $410K | Hold |
35,744
| – | – | ﹤0.01% | 709 |
|
|
2019
Q2 | $470K | Hold |
35,744
| – | – | ﹤0.01% | 676 |
|
|
2019
Q1 | $541K | Hold |
35,744
| – | – | ﹤0.01% | 636 |
|
|
2018
Q4 | $614K | Hold |
35,744
| – | – | ﹤0.01% | 640 |
|
|
2018
Q3 | $527K | Sell |
35,744
-13,052
| -27% | -$192K | ﹤0.01% | 644 |
|
|
2018
Q2 | $1.16M | Sell |
48,796
-11,746
| -19% | -$280K | ﹤0.01% | 570 |
|
|
2018
Q1 | $1.55M | Buy |
+60,542
| New | +$1.55M | ﹤0.01% | 541 |
|